APA (7th ed.) Citation

JD, P., S, M., HR, M., SL, O., ZS, B., AH, S., & DA, S. (2024). Intranasal delivery of mitochondria targeted neuroprotective compounds for traumatic brain injury: Screening based on pharmacological and physiological properties. Journal of translational medicine, 22(1), 167. https://doi.org/10.1186/s12967-024-04908-2

Chicago Style (17th ed.) Citation

JD, Pandya, Musyaju S, Modi HR, Okada-Rising SL, Bailey ZS, Scultetus AH, and Shear DA. "Intranasal Delivery of Mitochondria Targeted Neuroprotective Compounds for Traumatic Brain Injury: Screening Based on Pharmacological and Physiological Properties." Journal of Translational Medicine 22, no. 1 (2024): 167. https://doi.org/10.1186/s12967-024-04908-2.

MLA (9th ed.) Citation

JD, Pandya, et al. "Intranasal Delivery of Mitochondria Targeted Neuroprotective Compounds for Traumatic Brain Injury: Screening Based on Pharmacological and Physiological Properties." Journal of Translational Medicine, vol. 22, no. 1, 2024, p. 167, https://doi.org/10.1186/s12967-024-04908-2.